Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

KALV vs ANL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KALV Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 8–2 Matrix Metrics)

KALV Overall Winner 6-Pillar Tally: KALV 4 – 1 ANL (1 Tie) Matrix Metrics: KALV 8 – 2 ANL

As of Nov 16, 2026, KalVista Pharmaceuticals, Inc. (KALV) is the stronger overall head-to-head candidate over ANL (ANL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KALV carries a Unified Composite Score of 55.1/100 (HOLD) at $27.00 (25.4x Forward P/E, -57.4% operating margin), whereas ANL carries 48.3/100 (HOLD) at $9.97 (N/M Forward P/E, -123.5% operating margin).

  • Growth vs. Quality Trade-Off: KALV earns the overall head-to-head edge with a stronger Unified Composite Score (55.1/100 HOLD vs. ANL 48.3/100 HOLD) and 0.85β · 2% Vol risk profile, whereas ANL leads top-line expansion (+178.1% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: KALV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.0); meanwhile ANL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KALV vs ANL
KALV NASDAQ Head-to-Head Winner
KalVista Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$27.00
+0.04% 1D
Market Cap $1.4B
TTM Revenue $114M
Forward P/E 25.4x
Beta / 30D Vol 0.85β · 2% Vol
Unified Composite Score
55.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (19.4% over 20 days), RSI 76
RSI-14: 76.0 · SMA20: $26.86 · SMA50: $24.01
ANL US Equity
ANL
Institutional Equity
$9.97
-6.03% 1D
Market Cap $677.5M
TTM Revenue $18M
Forward P/E N/M
Beta / 30D Vol 2.61β · 79% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 42
RSI-14: 41.7 · SMA20: $10.30 · SMA50: $12.92

6-Pillar Scorecard Institutional Category Breakdown (KALV 4 – 1 ANL)

Columns: Metric · KALV · ANL
1. Valuation Multiples KALV
Forward P/E 25.4x N/M
Trailing P/E 25.4x N/M
PEG Ratio N/M N/M
EV / Revenue 12.6x 37.5x
2. Growth & Scale KALV
Revenue Growth (YoY) +30.7% +178.1%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $114M $18M
Market Cap $1.4B $677.5M
3. Profitability & Quality KALV
Gross Margin 51.1% 100.0%
Operating Margin -57.4% -123.5%
Net Profit Margin -118.7% -124.8%
Return on Equity (ROE) -190.2% -20.2%
4. Balance Sheet & Cash Flow ANL
Cash Generation (TTM) -$138M EBITDA -$22M EBITDA
Cash Flow Margin -120.9% EBITDA Mgn -119.9% EBITDA Mgn
Net Cash / Leverage -190.2% ROE $3.34 Book/Sh · -20.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning KALV
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 88.9% (31st %ile) N/A (N/A)
Put/Call OI Skew 26.28x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KALV (8) vs ANL (2)
Institutional Metric KALV ANL Criterion Row Edge
Market Capitalization
Scale
$1.4B $677.5M Larger Scale KALV
Trailing P/E Ratio
Valuation
25.4x N/M Lower Multiple KALV
Forward P/E Ratio
Valuation
25.4x N/M Lower Multiple KALV
Revenue Growth (YoY)
Growth
+30.7% +178.1% Higher Growth ANL
Operating Margin (TTM)
Profitability
-57.4% -123.5% Higher Margin KALV
Net Profit Margin
Profitability
-118.7% -124.8% Higher Margin KALV
Return on Equity (ROE)
Capital Efficiency
-190.2% -20.2% Higher ROE ANL
52-Week Range Position
Momentum
100% ($10–$27) 56% ($1–$17) Stronger Trend KALV
Beta / 30D Volatility
Risk Regime
0.85β · 2% Vol 2.61β · 79% Vol Lower Realized Risk KALV
Unified Institutional Score
Composite Signal
55.1 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite KALV
Trailing 12M Revenue (USD)
Operating Scale
$114M $18M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
51.1% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 12.6x EV/Rev N/M PEG · 37.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$138M EBITDA (-190.2% ROE) -$22M EBITDA ($3.34 Book/Sh · -20.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KALV +20.3 pp
KALV: +1.09% · ANL: -19.21%
3M Horizon KALV +29.32 pp
KALV: +48.03% · ANL: +18.71%
6M Horizon ANL +1029.63 pp
KALV: +60.14% · ANL: +1089.77%
1Y Horizon ANL +487.12 pp
KALV: +106.26% · ANL: +593.38%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KALV vs ANL. Trailing 12-month operating profitability (KALV -57.4% vs ANL -123.5%) and valuation multiples (KALV 25.4x vs ANL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

KALV ADR TTM Benchmark FX-Normalized USD
TTM Revenue$114M
Gross Margin51.1%
Op. Margin-57.4%
ROE / Fwd P/E-190.2% · 25.4x
ANL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$18M
Gross Margin100.0%
Op. Margin-123.5%
ROE / Fwd P/E-20.2% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KALV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 88.9%
IV Percentile 31st %ile
Put/Call OI Skew 26.28x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact KALV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ANL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ANL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KALV Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.4B market capitalization and -57.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ANL Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $677.5M market capitalization and -123.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ KALV vs ANL Key Questions & Quantitative Answers

As of Nov 16, 2026, KalVista Pharmaceuticals, Inc. (KALV) is the stronger overall head-to-head candidate over ANL (ANL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KALV carries a Unified Composite Score of 55.1/100 (HOLD) at $27.00 (25.4x Forward P/E, -57.4% operating margin), whereas ANL carries 48.3/100 (HOLD) at $9.97 (N/M Forward P/E, -123.5% operating margin). Growth vs. Quality Trade-Off: KALV earns the overall head-to-head edge with a stronger Unified Composite Score (55.1/100 HOLD vs. ANL 48.3/100 HOLD) and 0.85β · 2% Vol risk profile, whereas ANL leads top-line expansion (+178.1% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: KALV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.0); meanwhile ANL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KALV leads the Growth & Scale pillar: KALV posts +30.7% YoY revenue growth and +0.0% YoY earnings growth on $114M TTM revenue (51.1% gross margin, -57.4% operating margin), compared with ANL at +178.1% YoY revenue growth and +0.0% YoY earnings growth on $18M TTM revenue (100.0% gross margin, -123.5% operating margin). On trailing 12-month operating scale, KALV generates $114M in USD-normalized revenue versus $18M for ANL. In operating R&D and SG&A reinvestment, KALV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ANL.

KALV screens cheaper on headline valuation multiples. KALV trades at 25.4x Forward P/E, 25.4x Trailing P/E, N/M PEG, and 12.6x EV/Revenue (-120.9% EBITDA margin), whereas ANL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 37.5x EV/Revenue (-119.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KALV (-190.2% ROE) versus ANL (-20.2% ROE) capital efficiency.

In options market volatility and institutional positioning, KALV carries 88.9% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 26.28x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.85β · 2% Vol realized risk). By comparison, ANL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.61β · 79% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.